Human acute myeloid leukemia cells (OCI-Aml-3)

The Human acute myeloid leukemia cells (OCI-Aml-3) are integral for advancing cancer research particularly in the study of leukemia's progression and treatment response as their transport and preservation via dry ice maintain cellular viability and functionality for subsequent experiments Utilizing these cells researchers can investigate the effects of novel therapies on cancer cell behavior enabling the exploration of potential treatment options and deeper understanding of disease mechanisms Additionally their circular single-cell suspended growth patterns allow for precise modeling of cellular interactions in vitro enhancing the reproducibility of experimental results and fostering innovations in targeted therapies This application supports the rigorous demands of research and development ensuring that advances in leukemia treatment can be effectively achieved through the study of OCI-Aml-3 cells